Bayesian Capital Management’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,189
Closed -$692K 163
2025
Q4
$692K Buy
+3,189
New +$698K 1.59% 16
2024
Q2
Sell
-3,982
Closed -$1.07M 836
2024
Q1
$1.07M Buy
+3,982
New +$1.01M 0.1% 272
2023
Q4
Sell
-4,823
Closed -$883K 824
2023
Q3
$883K Sell
4,823
-3,022
-39% -$617K 0.1% 251
2023
Q2
$1.85M Buy
7,845
+3,900
+99% +$821K 0.2% 140
2023
Q1
$800K Buy
+3,945
New +$821K 0.1% 274
2022
Q4
Sell
-1,666
Closed -$286K 842
2022
Q3
$286K Buy
+1,666
New +$326K 0.06% 427
2022
Q1
Sell
-6,851
Closed -$2.01M 805
2021
Q4
$2.01M Buy
6,851
+4,665
+213% +$1.3M 0.63% 30
2021
Q3
$554K Buy
+2,186
New +$568K 0.16% 172
2021
Q1
Sell
-5,158
Closed -$995K 577
2020
Q4
$995K Buy
+5,158
New +$867K 0.26% 105
2018
Q2
Sell
-4,300
Closed -$507K 632
2018
Q1
$507K Buy
+4,300
New +$516K 0.13% 267
2017
Q2
Sell
-5,000
Closed -$684K 478
2017
Q1
$684K Buy
+5,000
New +$636K 0.32% 97

Other funds holding EFX

Bayesian Capital Management's EFX Position: Q1 2026 in Review

Bayesian Capital Management sold out of Equifax (EFX) in Q1 2026, closing a stake of 3,189 shares — an estimated $692K sold.

Bayesian Capital Management first reported a position in EFX in Q1 2017 and held it in 11 quarters. The position peaked at $2.01M in Q4 2021. 870 funds tracked by Wall St. Rank hold EFX as of Q1 2026.

  • Bayesian Capital Management reported no remaining Equifax position as of Q1 2026 after selling out during the quarter.
  • Bayesian Capital Management sold 3,189 Equifax shares in Q1 2026, an estimated $692K.
  • Bayesian Capital Management first reported a position in Equifax in Q1 2017 and held it in 11 quarters.
  • Bayesian Capital Management's Equifax position peaked at $2.01M in Q4 2021.
  • 870 funds tracked by Wall St. Rank held Equifax as of Q1 2026.

Based on Bayesian Capital Management's 13F filing for Q1 2026, filed 15 May 2026.